appealing option, yet they may be too limited in flow and durability. 2 The AA-LVAD combines the benefit of a relatively quick insertion with sufficient circulatory support for restoration of end-organ function 4 and avoids the hazards of resternotomy and invasive surgery.
Pulmonary artery banding (PAB) for ventricular training followed by the double switch operation (DSO) is an attractive surgical option for suitable patients with congenitally corrected transposition of the great arteries (ccTGA). After repair, the systemic circulation is supported by the morphologic left ventricle (LV). Adoption of DSO was driven by the poor natural history of the systemic right ventricle (RV) and successful outcomes with DSO have been reported since the mid-1990s. 1 Although mortality after these operations is low with careful patient selection, the accurate prediction of adverse postoperative outcomes is difficult, and there remains an unpredictable risk of morbidity, takedown or reoperation. 2 Recent studies have demonstrated that perioperative changes in B-type natriuretic peptide (BNP) levels may predict postoperative morbidity and mortality after surgery for the repair or palliation of congenital cardiac defects. 3 However, the potential usefulness of preoperative BNP levels as predictors of postoperative outcomes in patients undergoing repair for ccTGA has not been investigated.
This pilot study hypothesized that preoperative BNP levels could be associated with unexpected outcomes after PAB and DSO in patients otherwise deemed to be suitable operative candidates on the basis of standard preoperative clinical, echocardiographic, and hemodynamic assessments.
MATERIALS AND METHODS Design and Participants
A pilot prospective cohort study was undertaken at Lucile Packard Children's Hospital Heart Center from November 2011 to November 2013. Eligible participants included all patients with ccTGA undergoing either PAB or DSO. Management followed standard institutional practices. Informed consent from the patients or their guardians was obtained before enrollment. The Stanford University Medical Center Institutional Review Board approved the study (IRB 22458).
Blood samples were obtained from a venous or arterial catheter less than 24 hours preoperatively and were assayed using a commercially available fluorescence immunoassay (Triage Meter Plus; Biosite Diagnostic, San Diego, Calif).
Outcome
The end point was a composite of adverse outcomes including death, cardiac arrest, need for extracorporeal cardiopulmonary life support or emergency reoperation.
Analysis
The 2-sided Fisher exact test was used to evaluate the association between increased BNP level (>300 pg/mL) and the binary composite adverse outcome. Exact logistic regression was used to estimate the corresponding odds ratio and 95% confidence interval. Statistical analyses were performed using Stata 13 (StataCorp LP, College Station, Tex).
RESULTS
Fifteen patients were approached and 13 were enrolled. Six patients underwent PAB and 5 underwent DSO. Two patients were excluded from the analysis: 1 who underwent a Glenn operation and 1 who underwent transplantation ( Table 1) .
Two patients experienced an adverse outcome: 1 developed severe hypotension requiring emergency reoperation to loosen the pulmonary artery (PA) band; 1 had an intraoperative cardiac arrest, treated successfully with resuscitation measures. None of the patients died. Both adverse outcomes were in patients undergoing PAB.
Preoperative BNP levels ranged from 8.3 to 366 pg/mL. The 2 patients with adverse outcome had preoperative BNP levels of 366 pg/mL and 331 pg/mL. All other patients had preoperative BNP levels less than 102 pg/mL. BNP was strongly associated with adverse outcome, particularly BNP greater than 300 pg/mL ( Figure 1 ). All patients met criteria for morphologic LV readiness for DSO or need for further retraining by PAB by clinical evaluation, assessment of LV ejection fraction and degree of mitral regurgitation measured by echocardiography, LV mass measured by magnetic resonance imaging (MRI), and peak systolic and end diastolic LV pressures measured at cardiac catheterization.
The observed association between preoperative BNP greater than 300 pg/mL and adverse outcome was statistically significant (P ¼ .015). The corresponding exact odds ratio was 22, with a 95% confidence interval of 1.36 to infinity. We were unable to adjust the analysis for heterogeneity by age, weight, gender, or differences in cardiac disease.
DISCUSSION
Outcomes after PAB and DSO in patients with ccTGA have continued to improve since the introduction of the repair. However, the incidence of in-hospital mortality 
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The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 5 remains high, with recent estimates ranging from 2% to 10%. 2 In this pilot study, we found that preoperative BNP levels were markedly higher in patients with adverse outcomes than in patients with good outcomes in a sample of patients all thought to be good candidates for surgery by the current standard preoperative evaluations by cardiac catheterization, echocardiography, and MRI. Morphologic LV readiness for DSO or need for further retraining by PAB was based on 5 criteria at our institution: LV ejection fraction and degree of mitral regurgitation measured by echocardiography, LV mass measured by MRI, and peak systolic and end diastolic LV pressures measured at cardiac catheterization. Other institutions use similar but not exactly the same criteria. 2, 4 Intraoperative PAB tightening is guided by simultaneous echocardiography and LV and systemic pressure measurements. A midline sternotomy is performed to expose the aorta and PA. Minimal dissection is performed to encircle the proximal main PA with a silicone rubber band (Dow Corning, Midland, Mich). The degree of band tightening is guided by simultaneous transesophageal echocardiographic analysis and direct proximal PA pressure, LV pressure, and central venous pressure (CVP, a marker of LV end diastolic pressure) measurement. As the band is tightened to achieve successively higher pressures, the LV is monitored for diminished systolic function. As the LV pressure increases, transesophageal echocardiographic analysis demonstrates shift of the intraventricular septum. Often we see a decrease in tricuspid regurgitation. The goal after PAB is to get to 100% systemic pressure in the LV, however we rarely achieve this. We usually achieve approximately 60% of systemic pressure with our first banding procedure. Frequently, if we go beyond 60% we see evidence of LV strain and decreased function as determined by (1) decreased shortening fraction; (2) mitral regurgitation; (3) increased CVP (a proxy for LV end diastolic pressure); (4) arrhythmias. If any of these develop, we reduce the tightness of the PAB until these resolve. BNP has emerged as a powerful biomarker of impaired myocardial performance. Landmark studies in adults demonstrate a cutoff of 100 pg/mL for the diagnosis of congestive heart failure. 5 Levels in congenital heart disease are much more diverse, and are likely both age and defect specific. We found that in ccTGA, a BNP level greater than 300 pg/mL was highly associated with an adverse outcome, although where the exact cutoff level lies will require further investigation. This is a meaningful finding because the exact preoperative hemodynamics that predict postoperative adverse outcomes in ccTGA remain elusive and suggest that measurement of BNP blood levels may be an important adjunct to the current preoperative evaluation.
